Shivalik Rasayan Limited
The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations.
What Shivalik files
- Others43
- Board Meeting10
- Important4
- Results3
- Dividend/Bonus3
- Updates1
Shivalik Rasayan received warnings from exchanges over an audit committee governance lapse: a meeting had only one independent director. The company states it's taking corrective actions to ensure future compliance.
Consolidated financials for Shivalik Rasayan Limited reveal a significant revenue growth, supported by a favorable market environment and enhanced operational efficiencies. The company reported total revenue of ₹120 crore for the quarter, marking an increase of 15% year-over-year. This growth can be attributed to rising demand for their products and...
Shivalik Rasayan Limited's Board has approved the unaudited financial results for the quarter and half-year ending September 30, 2024. The company's strategic focus remains on expanding its position in the agro-chemical and API markets, leveraging India’s growing share globally. **Financial Highlights:** The recently launched 2000 MT capacity block for insecticides...
Shivalik Rasayan has announced a board meeting with the following key financial metrics for the quarter and half-year ended September 30, 2024. Total revenue reached ₹150 crore, reflecting a robust year-over-year growth of 25%. This surge can be attributed to increased demand in both the agrochemical and pharmaceutical sectors, as...